Yahoo
OTC Markets OTCPK - Delayed Quote USD

Eurofins Scientific SE (ERFSF)

95.47 -2.38 (-2.43%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for ERFSF
  • Previous Close 97.85
  • Open 96.00
  • Bid 95.01 x 10000
  • Ask 98.75 x 40000
  • Day's Range 96.00 - 96.00
  • 52 Week Range 64.95 - 98.46
  • Volume 225
  • Avg. Volume 2,007
  • Market Cap (intraday) 16.336B
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) 28.41
  • EPS (TTM) 3.36
  • Earnings Date --
  • Forward Dividend & Yield 0.84 (0.88%)
  • Ex-Dividend Date Apr 28, 2026
  • 1y Target Est --

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.

www.eurofins.com

65,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

ERFSF
29.40%
CAC 40 (^FCHI)
2.21%

1-Year Return

ERFSF
38.97%
CAC 40 (^FCHI)
2.30%

3-Year Return

ERFSF
103.44%
CAC 40 (^FCHI)
16.77%

5-Year Return

ERFSF
13.85%
CAC 40 (^FCHI)
16.68%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 1.91B
Earnings --
Profit Margin 0.00%

Q1

FY25

Q3

FY25

Q1

FY26

Q2

FY26

0
500M
1B
2B
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.17%

  • Return on Assets (ttm)

    5.99%

  • Return on Equity (ttm)

    11.33%

  • Revenue (ttm)

    7.39B

  • Net Income Avi to Common (ttm)

    469.9M

  • Diluted EPS (ttm)

    3.36

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    617.8M

  • Total Debt/Equity (mrq)

    96.12%

  • Levered Free Cash Flow (ttm)

    339.56M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: